Gender gap in heart dysfunctions in SSc
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study
The diagnostic rate of systemic sclerosis demonstrates a strong gender bias. EUSTAR performed recently a prospective observational study using the latest 2013 data extract from the EULAR scleroderma trials and research (EUSTAR) cohort.
The study concluded that although more common in women, systemic sclerosis appears as strikingly more severe in men.
news & events
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.
We are happy to share with you our latest newsletter. Read about World Scleroderma Day 2021, projects, our next world congress and more.